Jones Financial Companies’s Milestone Pharmaceuticals MIST Stock Holding History

Jones Financial Companies’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.8K	Hold	16,000	–	–	﹤0.01%	3504
2026 Q1	$16.6K	Hold	16,000	–	–	﹤0.01%	3364
2025 Q4	$32.3K	Buy	16,000 +5,000	+45%	+$10.8K	﹤0.01%	2726
2025 Q3	$22K	Hold	11,000	–	–	﹤0.01%	2746
2025 Q2	$20.5K	Hold	11,000	–	–	﹤0.01%	2576
2025 Q1	$9.68K	Hold	11,000	–	–	﹤0.01%	2720
2024 Q4	$26K	Buy	11,000 +10,000	+1,000%	+$17.2K	﹤0.01%	2141
2024 Q3	$1.53K	Sell	1,000 -70	-7%	-$102	﹤0.01%	2732
2024 Q2	$1.41K	Buy	+1,070	New	+$1.72K	﹤0.01%	2229

Other funds holding MIST

PCM

Pavaki Capital Management Pueblo, Colorado $287M AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Jones Financial Companies's MIST Position: Q2 2026 in Review

Jones Financial Companies held its Milestone Pharmaceuticals (MIST) position steady in Q2 2026 at 16,000 shares worth $19.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3504.

Jones Financial Companies first reported a position in MIST in Q2 2024 and has held it in 9 quarters since. The position peaked at $32.3K in Q4 2025. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

Jones Financial Companies held 16,000 shares of Milestone Pharmaceuticals worth $19.8K as of Q2 2026.
Jones Financial Companies left its Milestone Pharmaceuticals share count unchanged in Q2 2026.
Milestone Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3504 holding.
Jones Financial Companies first reported a position in Milestone Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Jones Financial Companies's Milestone Pharmaceuticals position peaked at $32.3K in Q4 2025.
78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.